BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCT - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bioct.org
X-WR-CALDESC:Events for BioCT
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260924T120000
DTEND;TZID=America/New_York:20260924T130000
DTSTAMP:20260813T153034Z
CREATED:20260813T153034Z
LAST-MODIFIED:20260813T153034Z
UID:10003109-1790251200-1790254800@bioct.org
SUMMARY:Beyond the Pitch Webinar: What First-Time Founders Don't See Coming - Hosted by LaunchBio
DESCRIPTION:Almost no deal gets done in one meeting\, and the person you pitched is rarely the person who decides. A founder’s story has to survive being retold without you in the room\, adapt as you move from second meeting to partner presentation to diligence\, and keep working in the moments you least expect\, including the silence\, the soft no\, and the monthly update. \n\n\n\n\n\n\n\n\n\n\n\n\nDetails\n\n\n\n\nJoin LaunchBio for part three of our Beyond the Pitch series featuring Joanna Ghayad\, PharmD\, PCC\, Executive Coach and Business Advisor for first-time founders\, for a practical look at what actually happens after your pitch lands with an investor. \nIn this session\, Joanna addresses the three things founders consistently miss when preparing for investor conversations: \n\nHow to make your story portable enough that your champion can sell it internally\nHow to shift the altitude of your narrative as the process advances instead of repeating the same pitch\nHow to keep the story alive between meetings in ways that build trust and turn a “not now” into a future lead.
URL:https://bioct.org/event/beyond-the-pitch-webinar-what-first-time-founders-dont-see-coming-hosted-by-launchbio/
LOCATION:VIRTUAL
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260825T120000
DTEND;TZID=America/New_York:20260825T130000
DTSTAMP:20260724T160546Z
CREATED:20260724T160546Z
LAST-MODIFIED:20260724T160546Z
UID:10003094-1787659200-1787662800@bioct.org
SUMMARY:Beyond the Pitch:  Fundraising Advice for First-Time Founders - Hosted by LaunchBio
DESCRIPTION:A strong pitch deck is only one part of a successful fundraising process. LaunchBio’s Beyond the Pitch webinar series is designed to help life science founders better understand the investor perspective and prepare for productive fundraising conversations. Through candid discussions\, each session explores a different aspect of investor readiness\, from refining your story and anticipating due diligence questions to building relationships and navigating compensation expectations. Whether you’re preparing for LaunchBio’s Investor Connect program or meeting with investors on your own\, these sessions will help you approach every conversation with greater confidence and clarity. \n\n\n\n\n\n\n\n\n\n\n\n\nFundraising Advice for First-Time Founders \n\n\nJoin LaunchBio for the second session in our Beyond the Pitch series\, featuring Aimee Raleigh\, PhD\, Principal at Atlas Venture moderated by Ariana DaCruz from Stifel\, for a candid conversation on what it actually takes to get a fundraising process off the ground. \nA polished deck gets you in the room. What happens next depends on whether you understand how investors think\, how they evaluate opportunities\, where they get stuck\, and what makes them want to keep a conversation going. Aimee will share her perspective on what first-time founders most often get wrong\, and what the best early-stage pitches tend to get right: how to prepare before you start reaching out\, tell a compelling story\, and build momentum once you’re in the process. If you’re preparing for your first investor meetings or reworking your approach\, this is the conversation to be in. \n\n\n\n\n\n\n\n\nSpeakers: \n\n\n\n\n\n\nAimee Raleigh\, PhD\, Principal at Atlas Venture \nAt Atlas Venture Aimee works alongside stellar entrepreneurs to build companies focused on innovative therapies and exciting new biology. She serves as a board director at Travin Bio and several stealth newcos. Aimee is a board observer at Triveni Bio\, Vima Therapeutics\, and Remix Therapeutics. She was previously an observer at Kailera Therapeutics (NASDAQ: KLRA)\, Aiolos Bio (acquired by GSK) and Versanis Bio (acquired by Eli Lilly). Prior to joining Atlas\, Aimee was a life sciences consultant at L.E.K. Consulting. At L.E.K.\, she worked with pharmaceutical and biotechnology clients on strategy for early-stage therapies\, including asset diligence\, pipeline and indication prioritization\, and commercial planning. \n\n\nAriana DaCruz\, Senior Vice President\, Stifel Venture Banking \nAriana DaCruz is a Senior Vice President with Stifel Bank’s Venture Banking team\, where she partners\nwith venture-backed companies\, founders\, and investors across the life sciences and healthcare\necosystem. She works closely with emerging growth companies throughout their lifecycle\, providing\nbanking solutions and strategic connectivity to support innovation. With more than a decade of\nexperience in the venture and biotech community\, Ariana is passionate about fostering relationships\namong entrepreneurs\, investors\, and strategic partners and helping connect the people and ideas\nthat drive innovation
URL:https://bioct.org/event/beyond-the-pitch-fundraising-advice-for-first-time-founders-hosted-by-launchbio/
LOCATION:VIRTUAL
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260729T120000
DTEND;TZID=America/New_York:20260729T130000
DTSTAMP:20260724T160230Z
CREATED:20260724T160053Z
LAST-MODIFIED:20260724T160230Z
UID:10003093-1785326400-1785330000@bioct.org
SUMMARY:Compensation Confidential 2026: Preparing for Investors and Scaling Your Team - Hosted by LaunchBio
DESCRIPTION:A strong pitch deck is only one part of a successful fundraising process. LaunchBio’s Beyond the Pitch webinar series is designed to help life science founders better understand the investor perspective and prepare for productive fundraising conversations. Through candid discussions\, each session explores a different aspect of investor readiness\, from refining your story and anticipating due diligence questions to building relationships and navigating compensation expectations. Whether you’re preparing for LaunchBio’s Investor Connect program or meeting with investors on your own\, these sessions will help you approach every conversation with greater confidence and clarity. \n\n\n\n\n\n\n\n\n\n\n\n\nPreparing for Investors and Scaling Your Team \n\n\nBuilding a biotech company means making smart compensation decisions long before your first big hire. Join LaunchBio and the compensation experts at J.Thelander Consulting for a practical discussion designed to help CEOs and founders navigate compensation conversations with investors and build a hiring strategy that supports growth after the raise. \nThe first half of this webinar will focus on how to navigate and prepare for investor-facing compensation discussions\, including real-time benchmark data on total cash and equity for you and your team\, how to plan for dilution\, and how to formalize a compensation philosophy with a defined salary structure. Learn how to approach these compensation discussions with confidence and avoid common mistakes that can impact financing outcomes. \nNext\, we’ll explore what happens after the capital closes: how to structure competitive compensation packages\, attract top talent\, retain key employees\, manage refresh grants\, and ensure your option pool remains competitive to scale competitively in today’s market. Speakers will share exclusive data and practical insights on hiring\, retention\, and compensation planning for growing life science companies. \n\n\n\n\n\n\n\n\nSpeakers: \n\n\n\n\n\n\nJody Thelander\, Founder and CEO\, J.Thelander Consulting \nJ.Thelander Consulting is headed by Jody K. Thelander\, a compensation executive with a track record of successful results and three decades of professional experience. Jody has a keen understanding of business realities through a diversified background in compensation\, sales and customer service. Her surveys and resulting reports have become a well-respected and highly desired tool for compensation decision-makers in the private capital markets. J.Thelander Consulting provides board and compensation consulting to a full range of private companies and investment firms\, including life sciences and tech\, venture capital\, private equity and corporate venture. Jody also spent ten years with TRW Space and Defense\, both in Washington\, DC and San Francisco\, before starting her own firm. \n\n\nTim Lew\, MBA\, Managing Director / Venture Banking\, Stifel \nAs a managing director at Stifel Venture Bank focused on life science and healthcare\, Tim mentors and advises startups at all stages of their journey\, connecting them to the larger ecosystem and accelerating them to their next inflection point via company building and fundraising strategies. Tim is based in San Francisco Bay Area\, where he spent a majority of his career in medical device sales before moving to finance. Tim graduated from UC Santa Barbara with a Master of Science in evolutionary genetics along with an MBA from UNC Chapel Hill. \n 
URL:https://bioct.org/event/compensation-confidential-2026-preparing-for-investors-and-scaling-your-team-hosted-by-launchbio/
LOCATION:VIRTUAL
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260212T090000
DTEND;TZID=America/Los_Angeles:20260212T153000
DTSTAMP:20251104T215627Z
CREATED:20251104T215627Z
LAST-MODIFIED:20251104T215627Z
UID:10002937-1770886800-1770910200@bioct.org
SUMMARY:LaunchBio: Invest in Cures Rare Disease Forum
DESCRIPTION:Join us on February 12\, 2026 at the University of California San Francisco (UCSF) to explore the transformative potential of impact investing in addressing rare disease challenges. This annual forum highlights the promise of venture philanthropy and innovative collaborations\, offering hope for the commercialization of therapies that could revolutionize the treatment of rare diseases. \nLearn from venture leaders\, advocates\, researchers\, and entrepreneurs as they share insights on accelerating translational research and advancing cures for patients through strategic funding and collaboration. This signature event brings together investment professionals from leading venture philanthropy funds to discuss cutting-edge approaches to supporting and funding breakthrough therapies. It features main-stage sessions\, panel discussions\, intimate gatherings and high-level networking opportunities. \nDon’t miss a special screening of Stitching Strength at the end of the day\, followed by an audience Q&A with Richard Bedlack\, MD\, PhD and Catherine Lomen-Hoerth\, MD\, PhD. The screening is free to all and open to the public.
URL:https://bioct.org/event/launchbio-invest-in-cures-rare-disease-forum/
LOCATION:UCSF Mission Bay Conference Center\, 1675 Owens Street\, San Francisco
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251208T140000
DTEND;TZID=America/New_York:20251208T150000
DTSTAMP:20251104T214807Z
CREATED:20251104T214807Z
LAST-MODIFIED:20251104T214807Z
UID:10002936-1765202400-1765206000@bioct.org
SUMMARY:LaunchBio: Countdown to JPM
DESCRIPTION:The JPM Healthcare Conference is the biggest week in biotech dealmaking and preparation is everything. Join our expert panel of investors\, founders\, and communications pros to learn how to navigate JPM like a pro. \nWe’ll cover 2025 industry highlights and the 2026 outlook\, how to secure the right meetings\, sharpen your pitch\, make the most of networking opportunities\, and keep momentum going long after the week ends. Whether you’re a first-timer or a seasoned attendee\, you’ll walk away with actionable strategies and our JPM Success Checklist to help you turn conversations into capital and partnerships.
URL:https://bioct.org/event/launchbio-countdown-to-jpm/
LOCATION:VIRTUAL
END:VEVENT
END:VCALENDAR